Dylan Skola

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 3

Top Topics

Immune Response

Acute Myeloid Leukemia

Top Venues

Molecular cancer therapeutics

Science (New York, N.Y.)

Illumina, Inc.

University of California San Diego (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Illumina, Inc. Oct 06 2018

United States

Bioinformatics Scientist :: Bioinformatics

Education History

University of California San Diego

United States

PHD :: Bioinformatics & Systems Biology

Humboldt State University

United States

BSC :: Biology

Publications

Shweta Joshi, Kevin X Liu, Muamera Zulcic, Alok R Singh, Dylan Skola, Christopher K Glass, P Dominick Sanders, Andrew B Sharabi, Timothy V Pham, Pablo Tamayo, Daniel Shiang, Huy Q Dinh, Catherine C Hedrick, Guillermo A Morales, Joseph R Garlich, Donald L Durden
Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression. Molecular cancer therapeutics 19 (3) (2020)
Shweta Joshi, Alok R Singh, Kevin X Liu, Timothy V Pham, Muamera Zulcic, Dylan Skola, Hyun Bae Chun, Christopher K Glass, Guillermo A Morales, Joseph R Garlich, Donald L Durden
SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer. Molecular cancer therapeutics 18 (6) (2019)
David Gosselin, Dylan Skola, Nicole G Coufal, Inge R Holtman, Johannes C M Schlachetzki, Eniko Sajti, Baptiste N Jaeger, Carolyn O'Connor, Conor Fitzpatrick, Martina P Pasillas, Monique Pena, Amy Adair, David D Gonda, Michael L Levy, Richard M Ransohoff, Fred H Gage, Christopher K Glass
An environment-dependent transcriptional network specifies human microglia identity. Science (New York, N.Y.) 356 (6344) (2017)